ZOMETA^® effectively helps to protect patients like Anthony with lung cancer from the threat of SREs

Time to first SRE,* ZOMETA vs placebo in patients with advanced lung cancer and other solid tumours⁶

*Excludes hypercalcemia of malignancy.

ZOMETA significantly delayed SREs vs placebo by more than 2 months (P=.023)⁶
ZOMETA reduced the risk of SREs vs placebo by 27% (P=NS)⁶

ZOMETA can delay and reduce SREs in patients like Anthony with bone metastases from lung cancer and other solid tumours⁶

Page

1 2

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

ZOMETA® effectively helps to protect patients like Anthony with lung cancer from the threat of SREs

ZOMETA can delay and reduce SREs in patients like Anthony with bone metastases from lung cancer and other solid tumours6

ZOMETA^® effectively helps to protect patients like Anthony with lung cancer from the threat of SREs

ZOMETA can delay and reduce SREs in patients like Anthony with bone metastases from lung cancer and other solid tumours⁶